These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 1499085)
1. Modulation of carcinogenicity in 1,2,3,4-tetrahydro-7,12- dimethylbenz[a]anthracene (THDMBA) by fluorine substitution: crystal structures of the 5- and 6-fluoro regioisomers. Black SD; Sharma PK; Gallucci JC; Blackburn AC; Downs JW; Rinderle SJ; Witiak DT Carcinogenesis; 1992 Aug; 13(8):1337-43. PubMed ID: 1499085 [TBL] [Abstract][Full Text] [Related]
2. Comparative metabolism in vitro of a novel carcinogenic polycyclic aromatic hydrocarbon, 1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene, and its two regioisomeric B-ring fluoro analogues. Rinderle SJ; Black SD; Sharma PK; Witiak DT Cancer Res; 1992 Jun; 52(11):3035-42. PubMed ID: 1591719 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure determination of the adducts formed by electrochemical oxidation of 1,2,3,4-Tetrahydro-7,12-dimethylbenz[a]anthracene in the presence of deoxyribonucleosides or adenine. Mulder PP; Chen L; Sekhar BC; George M; Gross ML; Rogan EG; Cavalieri EL Chem Res Toxicol; 1996 Dec; 9(8):1264-77. PubMed ID: 8951228 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity, anchorage-independent growth, and DNA adduct formation in human neonatal fibroblasts by 1,2,3,4-tetrahydro-7,12-dimethylbenz(a)-anthracene (TH-DMBA), its six aryl fluoro regioisomers, and an exo methylene tautomer. Kumari HL; Milo GE; Witiak DT Teratog Carcinog Mutagen; 1990; 10(3):247-62. PubMed ID: 1975129 [TBL] [Abstract][Full Text] [Related]
5. Molecular structure of the K-region cis-dihydrodiol of 7,12-dimethylbenz[a]anthracene. Zacharias DE; Glusker JP; Harvey RG; Fu PP Cancer Res; 1977 Mar; 37(3):775-82. PubMed ID: 402208 [TBL] [Abstract][Full Text] [Related]
6. 11-Methylbenzo[a]pyrene: bay region distortions. Prout K; Smith AD; Daub GH; Zacharias DE; Glusker JP Carcinogenesis; 1992 Oct; 13(10):1775-82. PubMed ID: 1423837 [TBL] [Abstract][Full Text] [Related]
8. In vitro metabolism of selected fluoro analogs of 7,12-dimethylbenz[a]anthracene. Wong LK; Alvin JD; Zemaitis MA; Daniel FB Res Commun Chem Pathol Pharmacol; 1983 Jun; 40(3):417-28. PubMed ID: 6414062 [TBL] [Abstract][Full Text] [Related]
9. Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz(a)anthracene in mouse skin. Slaga TJ; Gleason GL; DiGiovanni J; Sukumaran KB; Harvey RG Cancer Res; 1979 Jun; 39(6 Pt 1):1934-6. PubMed ID: 109189 [TBL] [Abstract][Full Text] [Related]
10. Oxidation of the trans-3,4-dihydrodiol metabolites of the potent carcinogen 7,12-dimethylbenz(a)anthracene and other benz(a)anthracene derivatives by 3 alpha-hydroxysteroid-dihydrodiol dehydrogenase: effects of methyl substitution on velocity and stereochemical course of trans-dihydrodiol oxidation. Smithgall TE; Harvey RG; Penning TM Cancer Res; 1988 Mar; 48(5):1227-32. PubMed ID: 3124956 [TBL] [Abstract][Full Text] [Related]
11. Mass spectrometric analysis of 7-sulfoxymethyl-12-methylbenz[a]anthracene and related electrophilic polycyclic aromatic hydrocarbon metabolites. Lehner AF; Horn J; Flesher JW J Mass Spectrom; 2004 Nov; 39(11):1366-78. PubMed ID: 15532073 [TBL] [Abstract][Full Text] [Related]
12. X-ray refinement of the crystal and molecular structure of 1,12-dimethylbenz[a]anthracene. Jones DW; Shaw JD Carcinogenesis; 1987 Sep; 8(9):1323-6. PubMed ID: 3113756 [TBL] [Abstract][Full Text] [Related]
13. Molecular structures of the chemical carcinogens 7-chloromethylbenz(a)anthracene and 7-chloromethyl-12-methylbenz(a)anthracene. Glusker JP; Zacharias DE; Carrell HL Cancer Res; 1976 Jul; 36(7 PT 1):2428-35. PubMed ID: 1277150 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of a carcinogen:nucleoside adduct. Carrell HL; Glusker JP; Moschel RC; Hudgins WR; Dipple A Cancer Res; 1981 Jun; 41(6):2230-4. PubMed ID: 6786734 [TBL] [Abstract][Full Text] [Related]
15. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives. Utesch D; Glatt H; Oesch F Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447 [TBL] [Abstract][Full Text] [Related]
16. 7,12-Dimethylbenz[a]anthracene: refined structure, electron density distribution and endo-peroxide structure. Klein CL; Stevens ED; Zacharias DE; Glusker JP Carcinogenesis; 1987 Jan; 8(1):5-18. PubMed ID: 3100086 [TBL] [Abstract][Full Text] [Related]
17. Shapes of carcinogenic benz[alpha]anthracenes: an x-ray crystal structure analysis of 12-methylbenz[alpha]anthracene. Jones DW; Sowden JM Cancer Biochem Biophys; 1976; 1(6):281-8. PubMed ID: 1016936 [TBL] [Abstract][Full Text] [Related]
18. Carbocations from oxidized metabolites of benzo[a]anthracene: a computational study of their methylated and fluorinated derivatives and guanine adducts. Borosky GL; Laali KK Chem Res Toxicol; 2006 Jul; 19(7):899-907. PubMed ID: 16841957 [TBL] [Abstract][Full Text] [Related]
19. In vitro malignant transformation of mouse fibroblasts by non-K-region dihydrodiols derived from 7-methylbenz(a)anthracene, 7,12-dimethylbenz(a)anthracene, and benzo(a)pyrene. Marquardt H; Grover PL; Sims P Cancer Res; 1976 Jun; 36(6):2059-64. PubMed ID: 817799 [TBL] [Abstract][Full Text] [Related]
20. A computational study of carbocations from oxidized metabolites of dibenzo[a,h]acridine and their fluorinated and methylated derivatives. Borosky GL; Laali KK Chem Res Toxicol; 2005 Dec; 18(12):1876-86. PubMed ID: 16359178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]